Bhumika Patel, MD
Pediatric Allergy/Immunology · Saint Petersburg, FLNPI 1164711453
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,032 of the $3,621 with a category attached, or 83.7%. It is spread thinly across 26 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,048 and has fallen 79.5% since, to $214 in 2025.
Across 133 payments — averaging $27.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$545
- Sanofi$447
- Takeda Pharmaceuticals U.S.A., Inc.$383
- Sanofi-aventis U.S. LLC$354
- Pfizer$314
- Novo Nordisk$253
- plus $1K from 20 others
What the payments were for
- Consulting fees$1324%
- Food & beverage$3,03284%
- Education$45813%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 13 | $545 |
| Sanofi | 16 | $447 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $383 |
| Sanofi-aventis U.S. LLC | 4 | $354 |
| Pfizer | 18 | $314 |
| Novo Nordisk | 13 | $253 |
| Regeneron Healthcare Solutions, Inc. | 6 | $228 |
| Novartis | 7 | $172 |
| Medtronic | 1 | $132 |
| Covis Pharma GmbH | 6 | $131 |
| Genentech USA, Inc. | 4 | $100 |
| Optinose US, Inc. | 4 | $74 |
| Kaleo, Inc. | 3 | $59 |
| GSK | 3 | $58 |
| Incyte Corporation | 3 | $52 |
| CSL Behring | 2 | $48 |
| Kerecis Limited | 1 | $46 |
| AbbVie | 2 | $39 |
| Shire North American Group Inc | 2 | $38 |
| Lilly USA, LLC | 2 | $37 |
| Amgen | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Biocryst US Sales Co., LLC | 1 | $22 |
| Alk-abello, Inc | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Circassia Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,621 in reported general payments places this provider in the 55th percentile of 30 pediatric allergy/immunology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pediatric allergy/immunology in Saint Petersburg
- Panida SriaroonSaint Petersburg$70K
- Mark BallowTampa$324K
- Vivian Hernandez-TrujilloMiami Lakes$285K
- Jolan WalterSt Petersburg$232K
- Jennifer LeidingOrlando$214K
- Hary KatzJacksonville$67K
- Jonathan MalkaNorth Miami Beach$32K
- Johana Castro WagnerLargo$15K
- Diana MartinTampa$12K
- Sharon LeonardJacksonville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.